---
figid: PMC4632638__nihms617965f2
figtitle: 'Ibrutinib: a first in class covalent inhibitor of Bruton’s tyrosine kinase'
organisms:
- Homo sapiens
- Mus musculus
- Canis lupus familiaris
organisms_ner:
- Homo sapiens
- Canis lupus familiaris
- Mus musculus
- Danio rerio
pmcid: PMC4632638
filename: nihms617965f2.jpg
figlink: /pmc/articles/PMC4632638/figure/F2/
number: F2
caption: 'Ibrutinib targets BTK, a kinase that is critical for signal transduction
  through the B-cell receptor pathway.BTK: Bruton’s tyrosine kinase; CLL: Chronic
  lymphocytic leukemia.'
papertitle: 'Ibrutinib: a first in class covalent inhibitor of Bruton’s tyrosine kinase.'
reftext: Matthew S Davids, et al. Future Oncol. ;10(6):957-967.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9702757
figid_alias: PMC4632638__F2
figtype: Figure
redirect_from: /figures/PMC4632638__F2
ndex: b6c942ae-dec8-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4632638__nihms617965f2.html
  '@type': Dataset
  description: 'Ibrutinib targets BTK, a kinase that is critical for signal transduction
    through the B-cell receptor pathway.BTK: Bruton’s tyrosine kinase; CLL: Chronic
    lymphocytic leukemia.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD79A
  - CD79B
  - SYK
  - LYN
  - BTK
  - PRKCB
  - MYD88
  - CARD11
  - BCL10
  - MALT1
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - NFKB1
  - Cd79a
  - Cd79b
  - Syk
  - Lyn
  - Btk
  - Prkcb
  - Myd88
  - Card11
  - Bcl10
  - Malt1
  - Nfkb1
  - kita
  - ngfra
  - cd79a
  - cd79b
  - syk
  - lyn
  - si:ch73-206d17.1
  - btk
  - prkcbb
  - myd88
  - card11
  - bcl10
  - malt1
  - malt2
---
